Abstract
A reversed-phase high-performance liquid chromatography (HPLC) assay procedure for Progabide, its active acid metabolite (PGA), and its hydrolytic degradation product (SL79.182) has been developed. This highly specific technique has allowed the simultaneous determination of these drugs in aqueous samples, and when coupled with a single and easy extraction step, spiked plasma samples could also be analyzed. The method had a sensitivity of about 30, 45, and 100 ng/ml for Progabide, SL79.182, and PGA, respectively.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
J. P. Kaplan, B. M. Raizon, M. Desarmenien, P. Feltz, P. M. Headley, P. Worms, K. G. Lloyd, and G. Bartholini. J. Med. Chem. 23:702–704 (1980).
G. Bartholini, B. Scatton, B. Zivkovic, and K. G. Lloyd. In P. Krogsgaard-Larsen, J. Scheel-Krager, and H. Kofod (eds.), GABA-Neurotransmitters, Munksgaard, Copenhagen, 1979, pp. 326–339.
G. Gillet, J. Fraisse-Andre, C. R. Lee, L. G. Dring, and P. L. Morselli. J. Chromatogr. 230:154–161 (1982).
I. Johno, B. T. Ludwick, and R. H. Levy. J. Pharm. Sci. 71:633–636 (1982).
W. Yonekawa, H. J. Kupferberg, and T. Lambert. J. Chromatogr. 276:103–110 (1983).
P. Padovani, C. Deves, G. Bianchetti, J. P. Thenot, and P. L. Morselli. J. Chromatogr. 308:229–239 (1984).
V. Ascalone, P. Catalani, and L. Dal Bo'. J. Chromatogr. 344:231–239 (1985).
R. M. C. Dawson, D. C. Elliott, W. H. Elliott, and K. M. Jones. Data for Biochemical Research, Oxford University Press, London, 1969.
N. F. Farraj, S. S. Davis, G. D. Parr, and H. N. E. Stevens. Bioavailability of progabide in the rabbit (submitted for publication).
N. F. Farraj, S. S. Davis, G. D. Parr, and H. N. E. Stevens. The stability and solubility of progabide and its related metabolic derivatives. Pharm. Res., to be submitted, 1986.
H. Ko and E. N. Petzold. In K. Tsuji and W. Morozowich (eds.), GLC and HPLC Determination of Therapeutic Agents: Part 1, Marcel Dekker, New York, 1978, pp. 277–301.
P. L. Morselli. In G. Bartholini, L. Bossi, K. G. Lloyd, and P. L. Morselli (eds.), Epilepsy and GABA Receptor Agonists, L.E.R.S. Monograph Series, Vol. 3, Raven Press, New York, 1985, pp. 441–447.
R. H. Levy, I. Johno, A. J. Wilensky, W. H. Pitlick, P. N. Friel, and G. D. Anderson. In G. Bartholini, L. Bossi, K. G. Lloyd, and P. L. Morselli (eds.), Epilepsy and GABA Receptor Agonists, L.E.R.S. Monograph Series, Vol. 3, Raven Press, New York, 1985, pp. 231–241.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Farraj, N.F., Davis, S.S., Parr, G.D. et al. A Reversed-Phase High-Performance Liquid Chromatography Assay Procedure for Progabide and Its Related Metabolic Derivatives. Pharm Res 4, 28–32 (1987). https://doi.org/10.1023/A:1016421725650
Issue Date:
DOI: https://doi.org/10.1023/A:1016421725650